Literature DB >> 26474658

Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Kelly A Chamberlain1, Sonia E Nanescu2, Konstantina Psachoulia2, Jeffrey K Huang3.   

Abstract

Oligodendrocytes readily regenerate and replace myelin membranes around axons in the adult mammalian central nervous system (CNS) following injury. The ability to regenerate oligodendrocytes depends on the availability of neural progenitors called oligodendrocyte precursor cells (OPCs) in the adult CNS that respond to injury-associated signals to induce OPC expansion followed by oligodendrocyte differentiation, axonal contact and myelin regeneration (remyelination). Remyelination ensures the maintenance of axonal conduction, and the oligodendrocytes themselves provide metabolic factors that are necessary to maintain neuronal integrity. Recent advances in oligodendrocyte regeneration research are beginning to shed light on critical intrinsic signals, as well as extrinsic, environmental factors that regulate the distinct steps of oligodendrocyte lineage progression and myelin replacement under CNS injury. These studies may offer novel pharmacological targets for regenerative medicine in inflammatory demyelinating disorders in the CNS such as multiple sclerosis. This article is part of the Special Issue entitled 'Oligodendrocytes in Health and Disease'.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Multiple sclerosis; Myelin; Oligodendrocyte precursor cells; Oligodendrocytes; Regeneration; Remyelination

Mesh:

Year:  2015        PMID: 26474658      PMCID: PMC4841742          DOI: 10.1016/j.neuropharm.2015.10.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  201 in total

1.  Wnt signaling controls the timing of oligodendrocyte development in the spinal cord.

Authors:  Takeshi Shimizu; Tetsushi Kagawa; Tamaki Wada; Yuko Muroyama; Shinji Takada; Kazuhiro Ikenaka
Journal:  Dev Biol       Date:  2005-06-15       Impact factor: 3.582

2.  NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination.

Authors:  Xinhua Lee; Zhongshu Yang; Zhaohui Shao; Sheila S Rosenberg; Melissa Levesque; R Blake Pepinsky; Mengsheng Qiu; Robert H Miller; Jonah R Chan; Sha Mi
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

Review 3.  Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.

Authors:  Moses Rodriguez
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

4.  Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination.

Authors:  Thomas Seifert; Jan Bauer; Robert Weissert; Franz Fazekas; Maria K Storch
Journal:  Acta Neuropathol       Date:  2006-11-30       Impact factor: 17.088

5.  Changed distribution of sodium channels along demyelinated axons.

Authors:  J D England; F Gamboni; S R Levinson; T E Finger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 6.  Retinoid X receptor and its partners in the nuclear receptor family.

Authors:  F Rastinejad
Journal:  Curr Opin Struct Biol       Date:  2001-02       Impact factor: 6.809

7.  Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.

Authors:  Wu Yin; Bing Hu
Journal:  Exp Neurol       Date:  2013-11-18       Impact factor: 5.330

Review 8.  Axon-glial signaling and the glial support of axon function.

Authors:  Klaus-Armin Nave; Bruce D Trapp
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 9.  Mitochondrial changes within axons in multiple sclerosis: an update.

Authors:  Graham R Campbell; Nobuhiko Ohno; Doug M Turnbull; Don J Mahad
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

10.  PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage.

Authors:  N P Pringle; H S Mudhar; E J Collarini; W D Richardson
Journal:  Development       Date:  1992-06       Impact factor: 6.868

View more
  29 in total

1.  The Neural Cell Adhesion Molecule-Derived (NCAM)-Peptide FG Loop (FGL) Mobilizes Endogenous Neural Stem Cells and Promotes Endogenous Regenerative Capacity after Stroke.

Authors:  Rebecca Klein; Nicolas Mahlberg; Maurice Ohren; Anne Ladwig; Bernd Neumaier; Rudolf Graf; Mathias Hoehn; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Maria Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

2.  Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation.

Authors:  Brittney A Beyer; Mingliang Fang; Benjamin Sadrian; J Rafael Montenegro-Burke; Warren C Plaisted; Bernard P C Kok; Enrique Saez; Toru Kondo; Gary Siuzdak; Luke L Lairson
Journal:  Nat Chem Biol       Date:  2017-11-13       Impact factor: 15.040

3.  PTEN negatively regulates the cell lineage progression from NG2+ glial progenitor to oligodendrocyte via mTOR-independent signaling.

Authors:  Estibaliz González-Fernández; Hey-Kyeong Jeong; Masahiro Fukaya; Hyukmin Kim; Rabia R Khawaja; Isha N Srivastava; Ari Waisman; Young-Jin Son; Shin H Kang
Journal:  Elife       Date:  2018-02-20       Impact factor: 8.140

4.  Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination.

Authors:  Andrea Pennati; Emily A Nylen; Ian D Duncan; Jacques Galipeau
Journal:  J Neurosci       Date:  2020-05-19       Impact factor: 6.167

5.  Non-traditional roles of immune cells in regeneration: an evolutionary perspective.

Authors:  Beryl N Arinda; Yacoub A Innabi; Juris A Grasis; Néstor J Oviedo
Journal:  Development       Date:  2022-05-03       Impact factor: 6.862

Review 6.  Effect of Anesthesia on Oligodendrocyte Development in the Brain.

Authors:  Ningning Fu; Ruilou Zhu; Shuang Zeng; Ningning Li; Jiaqiang Zhang
Journal:  Front Syst Neurosci       Date:  2022-05-18

7.  Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke.

Authors:  Anne Ladwig; Rebecca Rogall; Jörg Hucklenbroich; Antje Willuweit; Michael Schoeneck; Karl-Josef Langen; Gereon R Fink; M Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-28       Impact factor: 4.147

8.  High-glucose medium induces cellular differentiation and changes in metabolic functionality of oligodendroglia.

Authors:  Priscila Machado da Rosa; Leo Anderson Martins Meira; Diogo Onofre Souza; Larissa Daniele Bobermin; André Quincozes-Santos; Marina Concli Leite
Journal:  Mol Biol Rep       Date:  2019-07-03       Impact factor: 2.316

Review 9.  Glial Cells Response in Stroke.

Authors:  Poonam Jadhav; Mayuri Karande; Abhishek Sarkar; Shubhrakanta Sahu; Deepaneeta Sarmah; Aishika Datta; Antra Chaudhary; Kiran Kalia; Arvind Sharma; Xin Wang; Pallab Bhattacharya
Journal:  Cell Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.046

10.  Oligodendrocytes enhance axonal energy metabolism by deacetylation of mitochondrial proteins through transcellular delivery of SIRT2.

Authors:  Kelly A Chamberlain; Ning Huang; Yuxiang Xie; Francesca LiCausi; Sunan Li; Yan Li; Zu-Hang Sheng
Journal:  Neuron       Date:  2021-09-09       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.